The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Dietary Intervention With Phytochemicals and Polyunsaturated Fatty Acids in Prostate Cancer Patients
Official Title: Prostate Phytochemical & PUFA Intervention - a Phase I/II Study
Study ID: NCT00433797
Brief Summary: We will study the effect of dietary intervention in patients with prostate cancer. Outcomes include serum PSA kinetics, as well as biomarkers of inflammation, antioxidant status, oxidative stress and oxidative damage in blood cells, plasma, urine and prostate tissues
Detailed Description: A total of 102 patients with localized prostate cancer will be included in the study. A the time of inclusion, the participants will be randomized to three groups. The intervention groups includes; control group, tomato group and multi-diet group. The intervention period is three week and will be completed before prostatectomy or radiation therapy. Biomarkers og inflammation includes: acute phase proteins, cytokines, chemokines and other inflammatory mediators. Biomarker of antioxidant status includes vitamin C, vitamin E, glutathione, carotenoids, total antioxidant capacity and total phenolics. Oxidative stress markers includes; malondialdehyde, isoprostanes, 8-hydroxy-deoxyguanosine, oxidized vitamin C, total lipidperoxides (d-ROM) and protein carbonyls.
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Oslo Universuty Hospital, Radiumhospitalet and Aker, Oslo, , Norway
Name: Wolfgang Lilleby, MD
Affiliation: Rikshospitalet-Radiumhospitalet, Oslo
Role: PRINCIPAL_INVESTIGATOR
Name: Sigbjørn Smeland, MD, PhD.
Affiliation: Rikshospitalet-Radiumhospitalet, Oslo
Role: PRINCIPAL_INVESTIGATOR